Search for: "Abbott Products Inc" Results 421 - 440 of 664
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Mar 2011, 4:21 pm by Marie Louise
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly…  well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) –… [read post]
17 Mar 2011, 12:31 am
Abbott Labs., 339 F.3d 1324, 1329 (Fed. [read post]
10 Mar 2011, 7:58 am by Maxwell Kennerly
Abbott Laboratories forecast NeoProfen could be sold for $450-500 per treatment course. [read post]
9 Mar 2011, 3:00 am by Marie Louise
Allergan, Inc (Chicago IP Litigation Blog) Synagis (Palivizumab) – US: PDL BioPharma settles Medimmune Synagis litigation for $93M (Patent Docs) TriCor (Fenofibrate) – US: Abbott and Elan end TriCor suit with Ranbaxy (Patent Docs) Valsartan – Norway: Oslo District Court holds Actavis’ Valsartan/HCTZ product infringes Novartis’ patent covering synthesis route for Valsartan; deals inter alia with scope of Valsartan SPC (The SPC Blog) [read post]
3 Mar 2011, 10:13 am by Stefanie Levine
Patent No. 6,920,952 entitled SNOWMOBILE WITH REAR ARRANGEMENT SUTABLE TO ACCEPT A TRANSPORTABLE OBJECT and owned by Bombardier Recreational Products Inc. [read post]
3 Mar 2011, 10:13 am by Stefanie Levine
Patent No. 6,920,952 entitled SNOWMOBILE WITH REAR ARRANGEMENT SUTABLE TO ACCEPT A TRANSPORTABLE OBJECT and owned by Bombardier Recreational Products Inc. [read post]
15 Feb 2011, 5:26 pm by Marie Louise
: Novozymes v Danisco (Holman’s Biotech IP Blog) US: Preliminary injunction softened after claims are rejected in reexamination: Celsis In Vitor v CellzDirect (Reexamination Alert) Products Alpharen – EU: General Court: Boards of appeal are judges not doctors! [read post]
8 Feb 2011, 10:51 pm by Marie Louise
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes… [read post]
8 Feb 2011, 1:42 pm by Steve Hall
And: The drug was developed by Abbott Laboratories in the 1930s and produced until about 2004, when Abbott spun off a new company called Hospira Inc. [read post]
2 Jan 2011, 9:18 pm by Patent Docs
Abbott Laboratories Inc. 1:10-cv-01140; filed December 28, 2010 in the District Court of Delaware Infringement of U.S. [read post]